12:00 AM
 | 
Jun 22, 2009
 |  BioCentury  |  Emerging Company Profile

More Efficient Resonance: Sidebar: Corporate Profile

Beactica AB

Uppsala, Sweden

Technology: Sprint fragment-based drug discovery platform

Disease focus: Undisclosed

Clinical status:...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >